Home / Drug shortages / Cetrorelix Acetate Injection

Cetrorelix Acetate Injection — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Cetrorelix Acetate Injection (injection) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 11/13/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0480-5795-08
Dosage Form
Injection
Presentation
Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)
Initial Posting
11/13/2025
Revised Date

FDA data resources